Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response

Abstract Body composition is an important predictor in cancer patients, with skeletal muscle loss and high adiposity associated with poorer prognosis. This study evaluated how body composition affects treatment efficacy in 48 women with metastatic breast cancer receiving trastuzumab deruxtecan. Usin...

Full description

Saved in:
Bibliographic Details
Main Authors: Shiran Yaacobi Peretz, Rivka Kessner, Yael Bar, Amir Sonnenblick, Shir Lerner, Ariella Deutsch-Lukatsky, Karteek Popuri, Mirza Faisal Beg, Shlomit Strulov Shachar
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-025-00754-7
Tags: Add Tag
No Tags, Be the first to tag this record!